In this interview, SmartTRAK hosts a distinguished panel featuring Andrew Jimenez, MD (Yale School of Medicine), Winston Gwathmey, MD (University of Virginia), and Kevin Whitten (chief commercial officer, AlloSource) to discuss the clinical realities of modern hip preservation. The conversation highlights the shift from time-consuming autograft preparations to innovative "off-the-shelf" allograft solutions. Specifically, the panel explores the operational and clinical advantages of AceConnex, a pre-prepared fascia lata allograft designed to reduce intra-op time and standardize outcomes in labral reconstruction procedures. Click on the following video to learn more (17:44 min). A link to download a complete transcript of the interview is also provided below.
SmartTRAK: Hi, this is David Shepard with SmartTRAK. It's my pleasure to be joined by Dr. Andrew Jimenez, the assistant professor of orthopedics and rehabilitation at Yale School of Medicine, and Dr. Winston Gwathmey, professor of orthopedic surgery at UVA. We're also joined by Kevin Whitten, chief commercial officer at AlloSource, and tonight we're going to be talking about AceConnex.
Thank you very much for joining us, gentlemen. And feel free to jump in at any time, so whoever wants to start with these questions, and again, feel free to interject and jump in. But the first thing I wanted to do is try to get a sense of exactly what type of clinical procedure we're doing here, or what's the issue that occurs with these patients, where AceConnex comes in and is an excellent solution for these patients.
Dr. Winston Gwathmey: I can get started. Hip arthroscopy is a procedure that addresses injuries of the hip that are soft tissue injuries, labral injuries, femoroacetabular impingement. And we've seen a proliferation of this procedure in the past 20 years or so. And with that, we're learning a lot more and more about how the hip functions. And what we're seeing in 2025 is that sometimes the labrum, the soft tissue gasket ring that fits around the hip joint, is not in a situation that can be repaired or salvaged. And so luckily, we've learned a procedure called a labral reconstruction in which we replace part or all of the labrum with the cadaver graft. And what that does is it provides a lot of labral functions and anatomy in a situation where the labrum is deficient or not repairable.
Dr. Andrew Jimenez: And just to piggyback off that, there's been a real evolution in terms of labral treatment and management. Early days of hip arthroscopy, starting off with just labral debridement and labral excision. As our techniques and our implants became better, we moved onto doing labral repair. And what we invariably came up with was ...
Want to learn more about the shift from time-consuming autograft preparations to innovative "off-the-shelf" allograft solutions? Click the button below to download and read the complete transcript of our roundtable discussion, conducted by David Shepard, SmartTRAK GM/Sr Analyst, Orthobio & Regen.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s proprietary methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.